Covid-19 vaccine 'Covishield', being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began today at the state-run Sassoon General Hospital here in Maharashtra on Monday, a senior official said."We have started the phase-III trials of the vaccine candidate.
We will administer dose to 150 to 200 volunteers," said Dr Muralidhar Tambe, Dean, Sassoon General Hospital, reported PTI."Those who are willing to volunteer for vaccination can contact on the following numbers--8550960196, 8104201267," a statement said.The phase II trial of Covishield was conducted at Bharti Vidyapeeth Medical College and King Edward Memorial (KEM) Hospital in Pune.The SII has partnered with British-Swedish pharma company.